Global Hematopoietic Stem Cells Transplantation Market Growth (Status and Outlook) 2025-2031

Global Hematopoietic Stem Cells Transplantation Market Growth (Status and Outlook) 2025-2031

The global Hematopoietic Stem Cells Transplantation market size is predicted to grow from US$ 2640 million in 2025 to US$ 3726 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.

Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.

LPI (LP Information)' newest research report, the “Hematopoietic Stem Cells Transplantation Industry Forecast” looks at past sales and reviews total world Hematopoietic Stem Cells Transplantation sales in 2024, providing a comprehensive analysis by region and market sector of projected Hematopoietic Stem Cells Transplantation sales for 2025 through 2031. With Hematopoietic Stem Cells Transplantation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hematopoietic Stem Cells Transplantation industry.

This Insight Report provides a comprehensive analysis of the global Hematopoietic Stem Cells Transplantation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hematopoietic Stem Cells Transplantation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hematopoietic Stem Cells Transplantation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hematopoietic Stem Cells Transplantation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hematopoietic Stem Cells Transplantation.

This report presents a comprehensive overview, market shares, and growth opportunities of Hematopoietic Stem Cells Transplantation market by product type, application, key players and key regions and countries.

Segmentation by Type:
Stem Cells Storage
Stem Cells Consumables

Segmentation by Application:
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis

Please note: The report will take approximately 2 business days to prepare and deliver.